HL Pharma shares pharmaceutical news, industry updates and practical guidance for sponsors, healthcare providers and supply partners across Australia.
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the publication of a manuscript titled…
read moreStocks of essential medicines are running short with health care professionals struggling to deal with post-COVID-19 medication shortages. Let HL Pharma assist where we can.
read moreA newly approved eye drop hitting the market on Thursday could change the lives of millions of Americans with age-related blurred near vision, a condition affecting mostly people 40 and older.
read more
